# A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

> **NCT00734474** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 1202 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY2189265
- **DRUG:** Sitagliptin
- **DRUG:** Placebo solution
- **DRUG:** Placebo tablet
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00734474
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-06
- **Final completion:** 2012-07
- **Target enrollment:** 1202 (ACTUAL)
- **Last updated:** 2015-04-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734474, "A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00734474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*